Article
Histone H3S28 Phosphorylation Promotes a Senescence-Associated Survival Program Following PARP Inhibition in Hormone Receptor-Positive Breast Cancer
2026-08-06
Abstract excerpt
<title>Abstract</title> <p> Background: PARP1 inhibitors (PARPi) are a key therapeutic strategy in BRCA1/2-mutated and increasingly in homologous recombination (HR)-positive breast cancers. However, resistance and relapse remain major challenges. While most studies focus on DNA repair restoration, chromatin-based mechanisms of PARPi response are less understood. PARP1 regulates DNA repair and chromatin organisat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b9adbfaf-2469-5874-8936-58f73e6b7b6b
- DOI
- 10.21203/rs.3.rs-10431382/v1
